• No results found

[PDF] Top 20 <p>Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells</p>

Has 10000 "<p>Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells</p>" found on our website. Below are the top 20 most common "<p>Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells</p>".

&lt;p&gt;Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells&lt;/p&gt;

<p>Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells</p>

... HCC cells were cultured and harvested to prepare the cell suspension, which was diluted using physiological ...6 cells/animal) were injected into subcutaneous position (sites) of nude ...HCC cells. ... See full document

13

&lt;p&gt;The TGF-&amp;beta;/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells&lt;/p&gt;

<p>The TGF-&beta;/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells</p>

... Radiofrequency ablation (RFA), which is a kind of interventional therapeutic strategy, involves local ablative therapy to selectively destroy tumor tissues and minimize damage to tissues surrounding the tumor. 6 RFA is a ... See full document

13

&lt;p&gt;HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b/ATG9A Axis in Hepatocellular Carcinoma&lt;/p&gt;

<p>HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b/ATG9A Axis in Hepatocellular Carcinoma</p>

... or antitumor in cancer ...cancer cells against cell death through catabolic pathway, 29 while Pan et al indicated autophagy promotes cancer cell apoptosis via degradation of fundamental cellular ... See full document

11

&lt;p&gt;The oncoprotein HBXIP facilitates metastasis of hepatocellular carcinoma cells by activation of MMP15 expression&lt;/p&gt;

<p>The oncoprotein HBXIP facilitates metastasis of hepatocellular carcinoma cells by activation of MMP15 expression</p>

... HBXIP enhances cell prolifera- tion and ...HCC cells, and upregulates miR-135a targeting the 3UTR of FOXO1 ...an effect on HCC metastasis and the underlying molecular mechanism is ... See full document

12

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells

... For subcutaneous tumor experiments, MHCC97-H cells were injected into nude mice to form subcutaneous tumors as mentioned above. Sorafenib (2 mg) was dissolved in a mixture of DMSO (10 μ L), PEG400 (50 μ L), and ... See full document

10

&lt;p&gt;Knockdown of LINC00473 Enhances Radiosensitivity in Hepatocellular Carcinoma via Regulating the miR-345-5p/FOXP1 Axis&lt;/p&gt;

<p>Knockdown of LINC00473 Enhances Radiosensitivity in Hepatocellular Carcinoma via Regulating the miR-345-5p/FOXP1 Axis</p>

... vital effect on the radiosensitivity of tumor cells by functioning as competing endogenous RNA ...nasopharyngeal carcinoma by sponging microRNA- 194-3p and increasing PRC1 ...the effect of ... See full document

11

Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma

Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma

... direct effect of CDK1 inhibitor alone or combined with sorafenib, we applied them to F1 generation PDX tumor models in vivo (Figure ...anticancer effect on the overall PDX tumor models was revealed (Figure ... See full document

14

&lt;p&gt;Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma&lt;/p&gt;

<p>Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma</p>

... Notes: (A) The effect of the incubation for 72 h with HGF (0.1 1nM) or 2E6 (1–25nM) at the indicated concentration. The cell line was analyzed using the Cell Counting Kit CCK- 8/WST-8 cell viability assay. Error ... See full document

12

&lt;p&gt;ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance&lt;/p&gt;

<p>ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance</p>

... vitro antitumor effect of ARQ-197 on HCC cells was examined by MTT ...2C) cells in a dose- dependent manner. Interestingly, we observed the effect of ARQ-197 was stronger in ... See full document

12

&lt;p&gt;Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents&lt;/p&gt;

<p>Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents</p>

... 43 Antitumor agents such as sorafenib, regorafenib, lenvatinib, anlotinib, or apatinib and the small-molecular inhibitors such as mTOR inhibitor (Rapamycin), PI3K/AKT inhibitor (LY294002), MAPK inhibitor ... See full document

12

&lt;p&gt;Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma&lt;/p&gt;

<p>Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma</p>

... Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality in the world. 1 The incidence of HCC in the United States (US) is progressively rising making it the fastest growing ... See full document

11

&lt;p&gt;The Roles Of Angiogenesis And Cancer Stem Cells In Sorafenib Drug Resistance In Hepatocellular Carcinoma&lt;/p&gt;

<p>The Roles Of Angiogenesis And Cancer Stem Cells In Sorafenib Drug Resistance In Hepatocellular Carcinoma</p>

... tumors, the expression of E-cadherin and CD90 were slightly elevated but this difference was not statistically signi fi cant (Figure 4A). In PLC/PRF/5 (Figure 4B) and HepG2 (Figure 4C) xenograft tumors, there was no sig- ... See full document

11

&lt;p&gt;Rare Site Hepatocellular Carcinoma Metastasis&lt;/p&gt;

<p>Rare Site Hepatocellular Carcinoma Metastasis</p>

... frequent hepatocellular carcinoma (HCC) metastases sites are, in des- cending order, lung, peritoneum, bone, spleen, adrenal gland, brain, pleura and ... See full document

6

&lt;p&gt;Thalassemia and hepatocellular carcinoma: links and risks&lt;/p&gt;

<p>Thalassemia and hepatocellular carcinoma: links and risks</p>

... While currently the presence of liver fat is unpredicta- bly associated with iron in the liver and with metabolic syndrome, TDT and NTDT patients, as a direct conse- quence of iron overload, frequently suffer from ... See full document

12

&lt;p&gt;miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B&lt;/p&gt;

<p>miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B</p>

... of cells, participates in the process of ribose nucleotide reduction into deoxyribose and plays a central role in nucleoside ...human cells, RR consists of 3 subunits, 1 large-subunit [ribonucleotide ... See full document

12

&lt;p&gt;TDO Promotes Hepatocellular Carcinoma Progression&lt;/p&gt;

<p>TDO Promotes Hepatocellular Carcinoma Progression</p>

... HCC cells were higher than those in normal liver ...glioma cells and in TNBC cell lines (MDA-231, BT549 and ...glioma cells and correlates with the proliferation ...glioma cells restored ... See full document

11

&lt;p&gt;Silencing of TAZ inhibits the motility of hepatocellular carcinoma cells through autophagy induction&lt;/p&gt;

<p>Silencing of TAZ inhibits the motility of hepatocellular carcinoma cells through autophagy induction</p>

... Cells were washed twice in cold PBS and lysed in RIPA lysis buffer containing 50 mM Tris, 0.15 M NaCl, 1 mM EGTA, 1% NP40, 0.25% SDS (Beyotime Institute of Biotechnology, Haimen, People ’ s Republic of China), ... See full document

11

&lt;p&gt;Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma&lt;/p&gt;

<p>Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma</p>

... epithelial cells dramatically alter their shape, exhibit increased motility and acquire a mesenchymal ...LO2 cells exhibited an increased expression of epithelial cell marker E-cadherin, and a decreased ... See full document

8

&lt;p&gt;MicroRNA-3651 promotes the growth and invasion of hepatocellular carcinoma cells by targeting PTEN&lt;/p&gt;

<p>MicroRNA-3651 promotes the growth and invasion of hepatocellular carcinoma cells by targeting PTEN</p>

... Huh-7 cells were subcutaneously injected into nude mice to establish tumor xenograft ...and p-Akt were detected with Western ...and p-Akt were quantified via normalization to ... See full document

10

&lt;p&gt;Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report&lt;/p&gt;

<p>Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report</p>

... According to the Barcelona Clinic Liver Cancer (BCLC) staging system, systemic therapies are the stan- dard treatment for BCLC stage C HCC. 8 Referring to the experience of other neoadjuvant chemotherapy for malig- nant ... See full document

5

Show all 10000 documents...